We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EUCRW
2901
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$24K ﹤0.01%
22,697
+6,766
+42% +$6.07K
TRVN
2902
DELISTED
Trevena, Inc.
TRVN
$23K ﹤0.01%
+22
New +$24.7K
URG
2903
Ur-Energy
URG
$537M
$22K ﹤0.01%
+15,685
New +$21.4K
NMTR
2904
DELISTED
9 Meters Biopharma
NMTR
$20K ﹤0.01%
+916
New +$22.5K
MBII
2905
DELISTED
Marrone Bio Innovations, Inc.
MBII
$17K ﹤0.01%
+10,300
New +$17.2K
AGG icon
2906
iShares Core US Aggregate Bond ETF
AGG
$138B
-14,849
Closed -$1.69M
APLT
2907
DELISTED
Applied Therapeutics
APLT
-11,090
Closed -$208K
ATEC icon
2908
Alphatec Holdings
ATEC
$1.49B
-985,487
Closed -$15.6M
ATLO icon
2909
AMES National
ATLO
$281M
-9,813
Closed -$251K
AVAL icon
2910
Grupo Aval
AVAL
$6.35B
-346,700
Closed -$2.16M
AWRE icon
2911
Aware
AWRE
$26M
-12,000
Closed -$44K
CALC icon
2912
CalciMedica
CALC
$19.1M
-14,745
Closed -$1.15M
CDXS icon
2913
Codexis
CDXS
$175M
-791,032
Closed -$18.1M
CGEM icon
2914
Cullinan Oncology
CGEM
$1.26B
-723,584
Closed -$30.2M
CNYA icon
2915
iShares MSCI China A ETF
CNYA
$208M
-20,300
Closed -$835K
COHN icon
2916
Cohen & Co
COHN
$38.7M
-13,400
Closed -$318K
DADA
2917
DELISTED
Dada Nexus
DADA
-386,741
Closed -$10.5M
DALN
2918
DELISTED
DallasNews
DALN
-5,578
Closed -$47K
EIG icon
2919
Employers Holdings
EIG
$864M
-369,408
Closed -$15.9M
ETNB
2920
DELISTED
89bio
ETNB
-8,513
Closed -$202K
FDMT icon
2921
4D Molecular Therapeutics
FDMT
$621M
-279,746
Closed -$12.1M
FOR icon
2922
Forestar Group
FOR
$1.49B
-9,971
Closed -$232K
GNSS icon
2923
Genasys
GNSS
$77.4M
-11,565
Closed -$77K
HAFC icon
2924
Hanmi Financial
HAFC
$956M
-22,040
Closed -$435K
HMY icon
2925
Harmony Gold Mining
HMY
$12.4B
-462,835
Closed -$2.02M

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.